Evaluation of Availability of Survey Data About Cannabis Use

Abstract

IMPORTANCEIn response to increasing public support for cannabis legalization, understanding associations of state and federal policy changes related to cannabis legalization with patterns of cannabis use is important. A challenge for public health monitoring and research is significant variation in data availability related to cannabis use behaviors and perceptions across and within states and over time, including the availability of prelegalization vs postlegalization data. OBJECTIVE To review data available on cannabis use and related behaviors over time in Massachusetts and the US. DESIGN, SETTING, AND PARTICIPANTS This case series examined state and national surveys on public health and related behaviors and outcomes to review availability of cannabis-related data for Massachusetts for 8 key indicators over time. Additionally, the Behavioral Risk Factor Surveillance System (BRFSS) and Youth Risk Behavior Surveillance System for all states were reviewed. The analysis was conducted between February 1, 2019, and March 18, 2020. EXPOSURES Surveys that enable state-level estimation of cannabis use and related behaviors. MAIN OUTCOMES AND MEASURES Eight key indicators related to cannabis use behaviors and perceptions: lifetime cannabis use, age of initiation, frequency of use, location of use, method of use, source of cannabis, perceptions of cannabis, and reason for use (ie, medical vs nonmedical).RESULTS There were 7 surveys that monitored cannabis use and related behaviors in Massachusetts for adolescents and adults. No surveys monitored all 8 indicators of interest, and availability over time was limited. In the most recent BRFSS, 24 states asked cannabis-related questions, meaning BRFSS data on cannabis use was lacking for more than half of the US adult population. In the Youth Risk Behavior Surveillance System, 36 states asked standard cannabis questions; most other states had at least 1 question related to cannabis use and frequency. CONCLUSIONS AND RELEVANCEThese findings of limitations of existing surveys, and particularly the lack of national questions in the BRFSS and Youth Risk Behavior Surveillance System, suggest that available data have substantial limitations for monitoring cannabis use. As cannabis policy changes continue, there is a need to remain focused on the availability of high-quality data sources that allow for critical public health research.

Changes in Cannabis Consumption During the Global COVID-19 Lockdown: The International COVISTRESS Study

“…Additionally, the natural turnover between being a cannabis user or not is impossible to assess, and reaching robust conclusions about the effects of the lockdown thus warrants further research. Another limitation concerns the fact that the survey was not validated, although most of the other studies on cannabis use ask a comparable question about consumption ( 47 , 48 ). Similarly, our questionnaire did not produce data about addictive behavior.…”

Cannabis attitudes and patterns of use among followers of the Allergy & Asthma Network

“…Long-term studies are assessing about cannabis use in adolescents, young adults, and adults living in states in which cannabis is legal and illegal (See E-Supplement). 46,47,48 Only J o u r n a l P r e -p r o o f 37.5% of current cannabis users indicated wanting to discuss cannabis with their physician and current cannabis users indicated that 41% of their physicians asked about cannabis either verbally or on an intake form. Perhaps so few cannabis users want to discuss cannabis with their physician because they are deriving beneficial effects that outweigh the impact on their disease and do not want to be told to stop smoking or vaping cannabis, despite the scant research on the long-term effects of inhaling cannabis on the lungs.…”

Reasons for individual and concurrent use of vaped nicotine and cannabis: their similarities, differences, and association with product use

“…This pilot study provides preliminary data examining the association between reasons for product use and co-use behaviors, including direct comparisons of reasons for using vaped nicotine, vaped cannabis, and smoked cannabis. While the measures included in this study provide a more detailed assessment of these issues than what is available in larger-scale surveys (Geissler et al, 2020 ), there are some limitations. First, these findings should be considered exploratory considering the small sample size and convenience sampling method.…”